|
|
|
| Analysis of Professor Cheng Weiping’s medication rule in the treatment of ischemic stroke based on data mining |
| LIU Yue1 CHENG Guangyu2 CHENG Weiping3#br# |
1.Graduate School, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150001, China;
2.Epilepsy Diagnosis and Treatment Center, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150001, China;
3.the Second Department of Acupuncture, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150001, China |
|
|
|
Abstract Objective To summarize the prescription and medication rule of Professor Cheng Weiping in the treatment of ischemic stroke. Methods The electronic medical record data of Professor Cheng Weiping in outpatient department of First Affiliated Hospital, Heilongjiang University of Chinese Medicine from January 2018 to June 2021 were extracted, related medical records were screened, processed and input into traditional Chinese medicine inheritance computing platform V3.0. Statistical methods such as frequency analysis, cluster analysis and association rules were used to summarize core drugs and summarize the rules of differentiation and treatment. Results A total of 273 prescriptions involving 162 Chinese medicines were included. There were ten Chinese medicines with use frequency > 100, and Persicae Semen and Carthami Flos were used 155 times. There were nine categories of drug efficacy use frequency > 100, and 34 groups of drug combinations ≥60; there were 31 drug combinations with the confidence of drug pair association coefficient ≥0.85. Conclusion Professor Cheng Weiping’s main principles for the treatment of this disease are “promoting blood circulation for removing blood stasis, dispelling wind and evil, purging phlegm and clearing collaterals, tonifying deficiency and invigorating spleen and permeating dampness”.
|
|
|
|
|
|
[1] 赵欣，周明.中医中药中医药治疗缺血性中风的研究进展[J].医学综述，2021，27（22）：4548-4552.
[2] Cui P，McCullough LD，Hao J. Brain to periphery in acute ischemic stroke：Mechanisms and clinical significance [J]. Front Neuroendocrinol，2021，63：100932. DOI：10.1016/j.yfrne.2021.100932.
[3] 黄先平，操良松.养阴熄风通络汤联合血栓通对中风偏瘫神经功能恢复影响[J].中华中医药学刊，2018，36（7）：1647-1650. DOI：10.13193/j.issn.1673-7717.2018.07.029.
[4] 任小巧.探析中医“整体观念”在“脑卒中”防治中的价值[J].中国中医基础医学杂志，2019，25（7）：880-882.
[5] 马蓉，徐弘扬，杨锡彤，等.急性脑卒中治疗的研究进展[J].重庆医学，2019，48（6）：1010-1013，1017.
[6] 李强.中西医结合治疗缺血性中风恢复期痰瘀阻络型疗效观察[J].实用中医药杂志，2021，37（6）：995-996.
[7] 王陇德，刘建民，杨弋，等.我国脑卒中防治仍面临巨大挑战—《中国脑卒中防治报告2018》概要[J].中国循环杂志，2019，34（2）：105-119.
[8] 董子源，王长德.缺血性中风急性期中医辨证论治的研究进展[J].世界中医药，2021，16（24）：3708-3712.
[9] 赵楠楠，陈丽霞.抗血小板药物治疗高危非致残性缺血性脑卒中研究的进展[J].心血管康复医学杂志，2021，30（5）：620-622.
[10] Pilato F，Calandrelli R，Capone F，et al. New Perspectives in Stroke Management：Old Issues and New Pathways [J]. Brain Sci，2021，11（6）：767. DOI：10.3390/brainsci11060767.
[11] 彭天忠，黄学娣，胡穗发，等.中西医结合卒中单元治疗缺血性脑卒中恢复期临床研究[J].中国中医药现代远程教育，2021，19（18）：139-142.
[12] 邓福华.针灸疗法联合通络扶正汤治疗老年缺血性脑卒中后偏瘫的临床疗效及其对神经功能的影响[J].临床合理用药杂志，2021，14（27）：143-145. DOI：10.15887/j.cnki.13-1389/r.2021.27.051.
[13] 宋民君.补阳还五汤联合西药治疗缺血性脑中风45例临床观察[J].黑龙江中医药，2021，50（4）：64-65.
[14] 毕阿迪.急性缺血性中风早期中医药康复疗法的临床观察[J].中国医药指南，2021，19（22）：115-116. DOI：10.15912/j.cnki.gocm.2021.22.052.
[15] 贾建平.神经病学[M].7版.北京：人民卫生出版社，2013.
[16] 喻腾云，吴艳华，孙寒静，等.缺血性脑卒中中医病因病机的层次关系[J].吉林中医药，2016，36（4）：328-331.
[17] 陈湘君.中医内科学[M].2版.上海：上海科学技术出版社，2013：388-389.
[18] 胡彩云.基于数据挖掘技术总结赵建军教授治疗缺血性中风恢复期临床经验[D].长春：长春中医药大学，2021. DOI：10.26980/d.cnki.gcczc.2021.000377.
[19] 马萌.有关肺与中风病机问题的商榷[J].中华中医药杂志，2016，31（3）：762-765.
[20] 张习东.中风从肺经论治刍议[J].广西中医药，2015，38（2）：39-40.
[21] 杨利，黄燕，蔡业峰，等.1418例中风患者痰瘀证候分布和演变规律探析[J].辽宁中医杂志，2004，13（6）：459-460.
[22] 吴迪，程为平.黑龙江地区脑卒中患者中医体质状况及相关因素分析[J].中医药通报，2021，20（1）：58-60，72.
[23] 金佳欣.缺血性中风始发态痰热证的临床特点及形成影响因素的研究[D].北京：北京中医药大学，2021. DOI：10.26973/d.cnki.gbjzu.2021.000488.
[24] 吴秀芬.基于文献分析的缺血性脑卒中状态辨识与相关因素研究[D].福州：福建中医药大学，2020. DOI：10. 27021/d.cnki.gfjzc.2020.000443.
[25] 张雅筠，康永，倪艳，等.基于CiteSpace的注射用红花黄色素研究现状可视化分析[J].中国医药科学，2022， 12（3）：67-70.
[26] 褚振翔.注射用红花黄色素治疗中风病血瘀证（脑梗塞）的临床研究[D].武汉：湖北中医药大学，2012. |
|
|
|
